Recruiting

Observational Study

Sponsor:

University of Rochester

Code:

NCT07630389

Conditions

Myotonic Dystrophy Type 1

Congenital DM1

Juvenile DM1

Childhood DM1

Eligibility Criteria

Sex: All

Age: 0 - 17

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Myotonic dystrophy type 1 (DM1) can affect people in many different ways, even in the same family. The symptoms that children experience can be different and more severe than adults. Prior studies in children have been limited because only a small number of children could participate. In this study, we hope to learn more about these differences and what causes them.

This is an observational study conducted in participants' homes and does not require travel. Instead, we will use video calls to talk with children and their parents/guardians about DM1 symptoms and how it affects the child's muscles, heart, and brain. We'll send families an iPad and the other tools they need for the study. During the video call, kids will do some simple activities to see how their body moves and functions. Parents/guardians might need to help their child with some of these activities.

After the video visit, we'll get a small blood sample from the child. This can be done at a local lab or even at home. We'll then look at the child's genes in the blood sample to understand how they might be linked to their symptoms. Parents/guardians can chose to have their child's genetic test result returned to them.

Conditions

Myotonic Dystrophy Type 1

Congenital DM1

Juvenile DM1

Childhood DM1

Study ID

NCT07630389

Start date

Nov 13, 2023

Status verified date

Feb, 2026

Completion date

Jan 1, 2030

Anticipated

Primary completion date

Jan 1, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 17

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age 0-17 years
  • Clinical diagnosis of congenital, childhood, or juvenile DM1
  • English speaking
  • Parent or guardian willing to assist and provide consent for participation
  • If appropriate based on age and developmental level, child willing to provide assent for their own participation
  • Available wifi

Exclusion Criteria:

  • Presence of any other non-DM1 illness or disease (e.g. other neuromuscular disorder, cerebral palsy, or other genetic or acquired disorder affecting the central or peripheral nervous system) that could interfere with study results in the opinion of the site investigator
  • Significant recent trauma or injury prior to the RSV that could affect functional assessment

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Remote assessment of cognitive function [ Time Frame: 12 months ]
  • Remote assessment of grip strength [ Time Frame: 12 months ]
  • Remote assessment of Video Hand Opening Time (VHOT) [ Time Frame: 12 months ]
  • 10 Meter Walk/Run Test [ Time Frame: 12 months ]
  • Genetic Test [ Time Frame: At baseline ]
  • Remote assessment of activity [ Time Frame: 12 months ]

Central Contacts and Locations

Central contacts

Locations

University of Rochester

Recruiting

Rochester, New York, United States, 14642

Contacts

Principal Investigator:

Johanna Hamel, MD

More Information

Sponsor

University of Rochester

Last update posted

Jun 5, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Rochester on 2026-06-05.